Abiopharma

🔍 Christianson Jon (Executive)

Company: Palomar Holdings, Inc. (PLMR)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Acquired 1,020 shares of Common Stock (RSUs) (Direct)
  Date: 2026-08-18 | Code: M | equity_swap_involved: false | shares_owned_after: 67,498.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 528 shares of Common Stock (RSUs) at $127.7463 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 66,970.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,020 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-08-18 | Code: M | equity_swap_involved: false | shares_owned_after: 1,020.00 | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the RSU award agreement required to cover minimum statutory tax withholding obligations that became due upon the RSU vesting event.
• F2: Includes 2,471 shares purchased pursuant to the Palomar Holdings, Inc. 2019 Employee Stock Purchase Plan (ESPP).
• F3: The original RSU grant was for 20,396 shares on 11/18/2021. Subject to continuing service with the Company, the restricted stock units shall vest as follows: 4,079 units shall vest on the first year anniversary of the date of the grant; 4,079 units shall vest on the second year anniversary of the date of the grant; 4,078 units shall vest on the third year anniversary of the date of grant; and 1,020 units shall vest quarterly following the third anniversary date of the grant.